Europa-Marktprognose für Immunhistochemie bis 2028 – Auswirkungen von COVID-19 und regionale Analyse nach Anwendung (Diagnostik und Arzneimitteltests), Produkt (Antikörper, Ausrüstung, Reagenzien und Kits) und Endbenutzer (Krankenhäuser und Diagnoselabore, Forschungsinstitute und andere)

Markteinführung

Europa ist nach Großbritannien, Deutschland, Frankreich, Italien, Spanien und dem Rest der zweitgrößte Markt für Immunhistochemie Europas leisten den größten Beitrag zu diesem Markt in dieser Region. Deutschland war im Prognosezeitraum Marktführer. In Deutschland ist in den letzten Jahren ein enormer Anstieg der Krebsfälle zu verzeichnen; Laut dem Global Cancer Observatory wurden beispielsweise im Jahr 2020 insgesamt 6.28.519 neue Fälle bei beiden Geschlechtern und allen Altersgruppen festgestellt, zusammen mit 69.697 (11,1 %) Fällen von Brustkrebs und 67.959 (10,8 %) Fällen. Prostatakrebs, 64.804 (10,3 %) Lungenkrebs, 57.528 (9,2 %) Darmkrebs, 35.147 (5,6 %) Blasenkrebs und 333.384 (53 %) andere Krebsarten. Die Immunhistochemie wird häufig bei der Diagnose und Behandlung von Krebs eingesetzt. Daher steigt die Nachfrage nach Immunhistochemie im Land. Die Prävalenz von Herz-Kreislauf-Erkrankungen nimmt im Land zu. Die ältere Bevölkerung trägt maßgeblich zum Anstieg der Prävalenz von Herz-Kreislauf-Erkrankungen bei. Der demografische Wandel stellt die Patientenversorgung vor große Herausforderungen. Auch die Zahl chronischer Erkrankungen nimmt mit der zunehmenden Alterung der Bevölkerung stetig zu. Gleichzeitig steigt der Kostendruck im Gesundheitswesen. Wie das Max-Planck-Institut 2019 angibt, leiden etwa 30-40 % der Erwachsenen im Land an Bluthochdruck. Die Inzidenz nimmt mit zunehmendem Alter zu, und Menschen über 60 haben ein höheres Risiko, an Herz-Kreislauf-Erkrankungen zu erkranken. IHC erfreut sich im Bereich der klinischen Diagnostik immer größerer Beliebtheit, da es zur Diagnose chronischer Krankheiten wie Krebs, Infektionskrankheiten, Herz-Kreislauf-Erkrankungen und Autoimmunerkrankungen eingesetzt wird. Daher wird erwartet, dass die zunehmende Prävalenz chronischer Krankheiten die Nachfrage nach immunhistochemischen Lösungen erhöhen und so das Marktwachstum fördern wird.

Länder in Europa, insbesondere Frankreich, sind aufgrund des COVID-19-Ausbruchs stark betroffen. Immunhistochemische Antikörper gegen Coronaviren sind immunologische Methoden, mit denen Mitglieder der Coronaviridae-Familie von RNA-Viren identifiziert werden können, die Vögel und Säugetiere infizieren. Nachfolgend sind Antikörper gegen Antigene aufgeführt, die von mehreren Coronavirus-Stämmen wie SARS-CoV-2, SARS-CoV, MERS und anderen nichtmenschlichen Krankheitserregern wie dem Katzen-Coronavirus exprimiert werden. Zu den häufigsten Zielen von Coronavirus-Antikörpern gehören Nukleokapsid (N) und Spike-Glykoprotein (S). Diese Antikörper sind für immunhistochemische Anwendungen bestimmt. Die immunhistochemische Analyse zeigt den Nachweis unterschiedlicher Expressionsniveaus des SARS-CoV-2-Coronavirus-Nukleokapsids und zeigt die Antikörperspezifität. Die immunhistochemische Analyse von SARS-CoV-2 Coronavirus NP unter Verwendung des monoklonalen SARS/SARS-CoV-2 Coronavirus NP-Antikörpers (B46F) (Kat.-Nr. MA1-7404) zeigt eine signifikante Färbung in mit SARS-CoV-2 infizierten menschlichen Lungen- und Plazentageweben im Vergleich zu den Kontrollgeweben ohne SARS-CoV-2. Forscher aus dem Vereinigten Königreich und Schweden verwendeten kürzlich eine äußerst empfindliche Multiplex-Immunhistochemie, um die ACE2-Expression in Gehirnperizyten von Patienten mit neurologischen Symptomen bei COVID-19-Patienten und Kontrollpersonen zu untersuchen. Sie verwendeten auch räumliche Immunphänotypisierung, um Entzündungen im Gehirngewebe von COVID-19-Patienten zu bewerten.

Marktüberblick und -dynamik

The Es wird erwartet, dass der europäische Markt für Immunhistochemie von 631,33 Millionen US-Dollar im Jahr 2021 auf 1.022,27 Millionen US-Dollar im Jahr 2028 wachsen wird; Es wird geschätzt, dass sie von 2021 bis 2028 mit einer jährlichen Wachstumsrate von 7,1 % wachsen wird. Herkömmliche Diagnosetests wurden im Allgemeinen in Labors mit teurer Ausrüstung und geschultem Personal durchgeführt, das für die Durchführung der Tests verantwortlich war. In den letzten Jahrzehnten haben sich diagnostische Tests schrittweise vom Zentrallabor zu patientennahen Teststandorten entwickelt. Die steigende Nachfrage nach Immunhistochemie, gepaart mit einem Mangel an Arbeitspersonal in den Immunologielabors, hat einen Bedarf an Automatisierung in der Immunhistochemie geschaffen. Die Automatisierung in der Immunhistochemie (IHC) bietet die Möglichkeit, die Empfindlichkeit, Reproduzierbarkeit und Standardisierung zu verbessern und bietet Vorteile wie eine Reduzierung der Arbeitszeit und die Einsparung von Reagenzien. Analytische Flexibilität ist einer der wesentlichen Faktoren, die in den Protokollen der Immunhistochemie erforderlich sind. Die Automatisierung des IHC trägt entscheidend dazu bei, die immunhistochemischen Techniken zu standardisieren. Darüber hinaus hilft es auch, 16-stufige manuelle Methoden auf 5-stufige Methoden zu vereinfachen, die dazu beitragen, die Anzahl der Arbeitskräfte zu minimieren. Darüber hinaus gewährleistet die automatisierte Immunhistochemie eine gleichbleibende Qualität und Entladung der Flecken und verbessert die Standardisierung und Optimierung der verschiedenen Techniken. Darüber hinaus kann die Automatisierung mit zuverlässigen und schnellen Ergebnissen diagnostische Testergebnisse schneller liefern, was zu einer Verkürzung der Krankenhausaufenthaltsdauer und damit zu Kosteneinsparungen führt. Daher dürften die verschiedenen Vorteile der Automatisierung in der Immunhistochemie (IHC) akzeptiert werden und in den kommenden Jahren zu einem der vorherrschenden Trends auf dem europäischen Markt werden.

Wichtige Marktsegmente

In Bezug auf das Produkt hatte das Antikörpersegment im Jahr 2020 den größten Anteil am europäischen Markt für Immunhistochemie. In Bezug auf die Anwendung hatte das Diagnostiksegment einen größeren Marktanteil der europäische Markt für Immunhistochemie im Jahr 2020. Darüber hinaus hielt das Segment Krankenhäuser und Diagnoselabore einen größeren Anteil am europäischen Markt für Immunhistochemie basierend auf dem Endverbraucher im Jahr 2020.

Wichtige Quellen und Unternehmen Gelistet

Einige wichtige primäre und sekundäre Quellen, auf die bei der Erstellung dieses Berichts über den europäischen Markt für Immunhistochemie Bezug genommen wird, sind Unternehmenswebsites, Jahresberichte, Finanzberichte, nationale Regierungsdokumente und Statistiken Datenbank, unter anderem. Zu den wichtigsten im Bericht aufgeführten Unternehmen gehören Abcam plc; Agilent Technologies, Inc.; Bio-SB; BIO-RAD LABORATORIES INC.; Cell Signaling Technology, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; und THERMO FISHER SCIENTIFIC INC.

Bericht über Kaufgründe

Um die europäische Marktlandschaft für Immunhistochemie zu verstehen und Marktsegmente zu identifizieren, die am wahrscheinlichsten eine starke Rendite garantieren
Bleiben Sie dem Rennen einen Schritt voraus, indem Sie die ständigen Veränderungen verstehen Wettbewerbslandschaft für den europäischen Markt für Immunhistochemie
Planen Sie M&A- und Partnerschaftsgeschäfte im europäischen Markt für Immunhistochemie effizient, indem Sie Marktsegmente mit den vielversprechendsten wahrscheinlichen Verkäufen identifizieren
Hilft dabei, fundierte Geschäftsentscheidungen aus dem Blickwinkel zu treffen und umfassende Analyse der Marktleistung verschiedener Segmente des europäischen Marktes für Immunhistochemie
Erhalten Sie eine Marktumsatzprognose für den Markt verschiedener Segmente von 2021 bis 2028 in der Region Europa.

Marktsegmentierung für Immunhistochemie in Europa

Europäischer Markt für Immunhistochemie – nach Produkt

Ausrüstung
Objektträgerfärbesysteme
Gewebe-Microarray-Systeme
Gewebeverarbeitungssysteme
Objektträgerscanner
Andere Geräte
Antikörper
Primärantikörper
Sekundärantikörper
Reagenzien
Histologische Färbungen
Blockierungs- und Fixierungsreagenzien
Chromogene Substrate
Fixierungsreagenzien
Stabilisatoren
Organische Lösungsmittel
Proteolytische Enzyme
Verdünnungsmittel
Kits

Europa Markt für Immunhistochemie – Nach Anwendung

Diagnostik
Krebs
Infektionskrankheiten
Autoimmunerkrankungen
Diabetes mellitus
Nephrologische Erkrankungen
Sonstiges
Drogentests

Europäischer Markt für Immunhistochemie – Nach Endbenutzer

Krankenhäuser und Diagnoselabore

Forschungsinstitute
Andere

Europa Markt für Immunhistochemie – nach Land

Europa Markt für Immunhistochemie – Unternehmensprofile

TABLE OF CONTENTS
1.             Introduction
1.1       Scope of the Study
1.2       The Insight Partners Research Report Guidance
1.3       Market Segmentation
1.3.1        Europe Immunohistochemistry Market – By Product
1.3.2        Europe Immunohistochemistry Market – By Application
1.3.3        Europe Immunohistochemistry Market – By End User
1.3.4        Europe Immunohistochemistry Market – By Country
2.             Key Takeaways
3.             Research Methodology
3.1       Coverage
3.2       Secondary Research
3.3       Primary Research
4.             Europe Immunohistochemistry Market – Market Landscape
4.1       Overview
4.2       Europe PEST Analysis
4.3       Experts Opinion
5.             Europe Immunohistochemistry Market – Key Market Dynamics
5.1       Market Drivers
5.1.1        Rising Incidences of Chronic and Infectious Diseases
5.1.2        Growing R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2       Key Market Restraints
5.2.1        Issues Related to Immunohistochemistry
5.3       Key Market Opportunities
5.3.1        Opportunities in Several Countries
5.4       Future Trends
5.4.1        Use of Automation in Immunohistochemistry
5.5       Impact Analysis
6.             Immunohistochemistry Market – Europe Analysis
6.1       Europe Immunohistochemistry Market Revenue Forecast and Analysis
7.             Europe Immunohistochemistry Market Analysis– By Product
7.1       Overview
7.2       Europe Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3       Antibodies
7.3.1        Overview
7.3.2        Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.3        Primary Antibodies
7.3.3.1      Overview
7.3.3.2      Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.4        Secondary Antibodies
7.3.4.1      Overview
7.3.4.2      Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4       Equipment Market
7.4.1        Overview
7.4.2        Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3        Slide Staining Systems
7.4.3.1      Overview
7.4.3.2      Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4        Tissue Microarrays
7.4.4.1      Overview
7.4.4.2      Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5        Tissue Processing Systems
7.4.5.1      Overview
7.4.5.2      Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6        Slide Scanners
7.4.6.1      Overview
7.4.6.2      Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7        Other Equipments
7.4.7.1      Overview
7.4.7.2      Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5       Reagents Market
7.5.1        Overview
7.5.2        Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.3        Histological Stains
7.5.3.1      Overview
7.5.3.2      Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.4        Blocking Sera & Reagents Market
7.5.4.1      Overview
7.5.4.2      Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.5        Chromogenic Substrates Market
7.5.5.1      Overview
7.5.5.2      Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.6        Stabilizers
7.5.6.1      Overview
7.5.6.2      Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.7        Proteolytic Enzymes
7.5.7.1      Overview
7.5.7.2      Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.8        Organic Solvents
7.5.8.1      Overview
7.5.8.2      Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.9        Fixation Reagents
7.5.9.1      Overview
7.5.9.2      Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.10     Diluents
7.5.10.1    Overview
7.5.10.2    Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.6       Kits Market
7.6.1        Overview
7.6.2        Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
8.             Europe Immunohistochemistry Market Analysis – By Application
8.1       Overview
8.2       Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3       Diagnostics
8.3.1        Overview
8.3.2        Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3        Cancer
8.3.3.1      Overview
8.3.3.2      Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4        Infectious Diseases
8.3.4.1      Overview
8.3.4.2      Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5        Autoimmune Diseases
8.3.5.1      Overview
8.3.5.2      Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6        Diabetes Mellitus
8.3.6.1      Overview
8.3.6.2      Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7        Nephrological Diseases
8.3.7.1      Overview
8.3.7.2      Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8        Others
8.3.8.1      Overview
8.3.8.2      Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4       Drug Testing
8.4.1        Overview
8.4.2        Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9.             Europe Immunohistochemistry Market Analysis– By End User
9.1       Overview
9.2       Europe Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3       Hospital & Diagnostic Laboratories
9.3.1        Overview
9.3.2        Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.4       Research Institutes
9.4.1        Overview
9.4.2        Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.5       Others
9.5.1        Overview
9.5.2        Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.          Europe Immunohistochemistry Market – Country Analysis
10.1    Europe: Immunohistochemistry Market Revenue and Forecasts to 2028
10.1.1     Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1    UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1    UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.2    UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.1.2.1        UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.1.2.2        UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.1.2.3        UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.1.3    UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.1.3.1        UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.1.4    UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.2    Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1    Germany Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.2    Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.2.2.1        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.2.2.2        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.2.2.3        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.2.3    Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.2.3.1        Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.2.4    Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.3    France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1    France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.2    France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.3.2.1        France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.3.2.2        France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.3.2.3        France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.3.3    France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.3.3.1        France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.3.4    France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.4    Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.1    Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.4.2    Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.4.2.1        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.4.2.2        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.4.2.3        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.4.3    Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.4.3.1        Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.4.4    Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.5    Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.1    Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.5.2    Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.5.2.1        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.5.2.2        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.5.2.3        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.5.3    Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.5.3.1        Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.5.4    Spain Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
10.1.1.6    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.1    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.6.2    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.6.2.1        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
10.1.1.6.2.2        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.6.2.3        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
10.1.1.6.3    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
10.1.1.6.3.1        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
10.1.1.6.4    Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
11.          Impact Of COVID-19 Pandemic on Europe Immunohistochemistry Market
11.1    Europe: Impact Assessment of COVID-19 Pandemic
12.          Industry Landscape
12.1    Overview
12.2    Organic Developments
12.2.1     Overview
12.3    Inorganic developments
12.3.1     Overview
13.          Company Profiles
13.1    Cell Signaling Technology, Inc.
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2    F. HOFFMANN-LA ROCHE LTD.
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3    MERCK KGaA
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4    PerkinElmer Inc.
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5    THERMO FISHER SCIENTIFIC INC.
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6    Abcam plc
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7    Agilent Technologies, Inc.
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8    BIO-RAD LABORATORIES INC.
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9    Danaher
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
13.10 Bio SB
13.10.1   Key Facts
13.10.2   Business Description
13.10.3   Products and Services
13.10.4   Financial Overview
13.10.5   SWOT Analysis
13.10.6   Key Developments
14.          Appendix
14.1    About The Insight Partners
14.2    Glossary of Terms

LIST OF TABLES
Table 1.             Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Table 2.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 4.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 7.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 8.             UK Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 9.             Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 11.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 14.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 15.          Germany Immunohistochemistry Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 16.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 18.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19.          France Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20.          France Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 21.          France Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 22.          France Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 23.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 24.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 25.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 26.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 27.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 28.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 29.          Italy Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 30.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 31.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 32.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 33.          Spain Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 34.          Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Application (USD Million)
Table 35.          Spain Immunohistochemistry Market Revenue and Forecast to 2028, by Diagnostics (USD Million)
Table 36.          Spain Immunohistochemistry Market Revenue and Forecast to 2028, by End User (USD Million)
Table 37.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 38.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 39.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 40.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 41.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Application (US$ Mn)
Table 42.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by Diagnostics (US$ Mn)
Table 43.          Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028, by End User (US$ Mn)
Table 44.          Organic Developments Done By Companies
Table 45.          Inorganic developments done by Companies
Table 46.          Glossary of Terms

LIST OF FIGURES
Figure 1.           Europe Immunohistochemistry Market Segmentation
Figure 2.           Europe Immunohistochemistry Market Segmentation, By Country
Figure 3.           Europe Immunohistochemistry Market Overview
Figure 4.           Antibodies Segment Held the Largest Share of the Market in 2021
Figure 5.           The UK to Show Significant Growth During Forecast Period
Figure 6.           Europe and PEST Analysis
Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to Europe Immunohistochemistry Market
Figure 8.           Europe Immunohistochemistry Market – Revenue Forecast and Analysis
Figure 9.           Europe Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 10.        Europe Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11.        Europe Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12.        Europe Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13.        Europe Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14.        Europe Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15.        Europe Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16.        Europe Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17.        Europe Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18.        Europe Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19.        Europe Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20.        Europe Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21.        Europe Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22.        Europe Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23.        Europe Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24.        Europe Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25.        Europe Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26.        Europe Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27.        Europe Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28.        Europe Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29.        Europe Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 30.        Europe Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31.        Europe Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32.        Europe Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33.        Europe Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34.        Europe Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35.        Europe Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36.        Europe Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37.        Europe Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 38.        Europe Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 39.        Europe Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40.        Europe Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41.        Europe Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42.        Europe: Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 43.        Europe Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 44.        UK Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45.        Germany Immunohistochemistry Products Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46.        France Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47.        Italy Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48.        Spain Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49.        Rest of Europe Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 50.        Impact of COVID-19 Pandemic in European Country Markets

Abcam plc
Agilent Technologies, Inc.
Bio SB
BIO-RAD LABORATORIES INC.
Cell Signaling Technology, Inc.
Danaher
F. HOFFMANN-LA ROCHE LTD.
MERCK KGaA
PerkinElmer Inc.
THERMO FISHER SCIENTIFIC INC.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe immunohistochemistry market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022

Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022

Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.